CORONA Remedies Limited (BOM:544644)
India · Delayed Price · Currency is INR 2,197.90
+47.05 (2.19%)
At close: Oct 28, 2026
CORONA Remedies Revenue
CORONA Remedies had revenue of 4.22B INR in the quarter ending June 30, 2026, with 21.90% growth. This brings the company's total for the last twelve months to 14.79B, up 19.24% year-over-year. In the fiscal year ending March 31, 2026, CORONA Remedies had annual revenue of 14.03B with 17.28% growth.
Revenue (ttm)
14.79B
Revenue Growth
+19.24%
P/S Ratio
9.10
Revenue / Employee
2.87M
Employees
5,153
Market Cap
134.59B
Revenue by Geography
- India 13.46B 95.9%
- outside India 569.10M 4.1%
Fiscal year ended Mar 31, 2026 See the full CORONA Remedies breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 14.03B | 2.07B | 17.28% |
| Mar 31, 2025 | 11.96B | 1.82B | 17.94% |
| Mar 31, 2024 | 10.14B | 1.30B | 14.75% |
| Mar 31, 2023 | 8.84B | 2.67B | 43.21% |
| Mar 31, 2022 | 6.17B | 411.66M | 7.14% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Marksans Pharma | 31.72B |
| Pfizer | 25.70B |
| Rubicon Research | 19.36B |
| CORONA Remedies | 14.79B |
| Sanofi Consumer Healthcare India | 9.50B |
| SMS Pharmaceuticals | 8.98B |
| Senores Pharmaceuticals | 6.80B |
| Sai Parenteral's | 5.26B |
CORONA Remedies News
- 1 month ago - CORONA Remedies Transcript: Transcript - Transcripts
- 1 month ago - CORONA Remedies Transcript: Transcript - Transcripts
- 2 months ago - CORONA Remedies Annual report - Filings
- 9 months ago - CORONA Remedies Transcript: Q2 25/26 - Transcripts
- 9 months ago - CORONA Remedies Quarterly report: Q2 2026 - Filings
- 9 months ago - CORONA Remedies Slides: Q2 2026 - Filings